Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Heart Lung. 2016 Apr 1;45(3):283–290. doi: 10.1016/j.hrtlng.2016.03.001

Table 2. Between group comparisons for cardiopulmonary exercise test variables at rest and peak exercise.

Rest Peak Exercise
CTL CF CTL CF

Total exercise duration, seconds - - 960 ± 41 729 ± 48*
Workload, watts - - 179 ± 11 100 ± 9*
RPE (6-20, Borg) 6.0 ± 0.0 6.0 ± 0.0 17.5 ± 0.2 16.8 ± 0.3
Cardiac hemodynamics
 SVI, mL/m2 40 ± 3 31 ± 3* 51 ± 2 45 ± 3
 QI, L/min/m 3.1 ± 0.2 2.6 ± 0.2* 9.1 ± 0.3 6.7 ± 0.5*
Ventilation or gas exchange
 VO2, mL/kg/min 5.9 ± 0.3 6.5 ± 0.4 33.2 ± 2 .0 22.6 ± 2 .2*
 VO2, L/min 0.4 ± 0.0 0.4 ± 0.0 2.3 ± 0.1 1.4 ± 0.1*
 VCO2, L/min 0.3 ± 0.0 0.4 ± 0.0 26 ± 0.2 1.6 ± 0.2 *
 RR, breaths/min 19 ± 2 22 ± 1 38 ± 2 36 ± 2
 VE, L/min 14 ± 1 16 ± 1 82 ± 4 56 ± 3*
 VT, L 0.8 ± 0.05 0.8 ± 0.07 2.2 ± 1.2 1.6 ± 1.2*
 PETCO2, mm Hg 30 ± 1 30 ± 1 35 ± 1 36 ± 1
 Ca-vO2, mL/100 mL/m2 5.8 ± 0.7 6.4 ± 1.1 15.7 ± 1.0 13.3 ±l.8
 SaO2, % 97.8 ± 0.3 95.7 ± 0.4* 96.9 ± 0.3 93.8 ± 1.2*
Heart rate or blood pressure
 HR, beats/min 81 ± 3 93 ± 4* 177 ± 2 145 ± 7*
 SBP, mm Hg 110 ± 2 106 ± 2 158 ± 4 142 ± 6*
 DBP, mm Hg 71 ± 1 70 ± 2 61 ± 4 67 ± 4
 MAP, mm Hg 84 ± 1 82 ± 2 93 ± 3 92 ± 4

Data are presented as mean ± SEM. CTL, control (n = 25); CF, cystic fibrosis (n = 17); RPE, rate of perceived exertion; SVI, stroke volume index; QI, cardiac index; VO2, oxygen uptake; VCO2, carbon dioxide output; RR, respiratory rate; VE, minute ventilation; VT, tidal volume; PETCO2, end-tidal partial-pressure carbon dioxide; Ca-vO2, arterial-mixed venous oxygen content difference; SaO2, peripheral oxygen saturation; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure. Between group comparisons were performed using Wilcoxon rank-sum tests for all variables. Within group comparisons were performed using paired Student's t-tests.

*

p<0.05, CTL vs. CF.

p<0.05, rest vs. peak exercise.